Zdorovʹe Rebenka (May 2018)

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 2)

  • A.E. Abaturov,
  • A.P. Volosovets,
  • T.P. Borysova

DOI
https://doi.org/10.22141/2224-0551.13.3.2018.132918
Journal volume & issue
Vol. 13, no. 3
pp. 334 – 337

Abstract

Read online

The review of the literature presents modern data on the activators of the transcription factor NFE2L2 and mimetics of antioxidant enzymes. Their effect on the oxidation-reduction state in diseases of the respiratory system is shown.

Keywords